CpG motifs are efficient adjuvants for DNA cancer vaccines

The Journal of Investigative Dermatology
Achim SchneebergerStephan N Wagner

Abstract

DNA vaccines can induce impressive specific cellular immune response (IR) when taking advantage of their recognition as pathogen-associated molecular patterns (PAMP) through Toll-like receptors (TLR) expressed on/in cells of the innate immune system. Among the many types of PAMP, immunostimulatory DNA, so-called CpG motifs, was shown to interact specifically with TLR9, which is expressed in plasmacytoid dendritic cells (pDC), a key regulatory cell for the activation of innate and adaptive IR. We now report that CpG motifs, when introduced into the backbone, are a useful adjuvant for plasmid-based DNA (pDNA) vaccines to induce melanoma antigen-specific protective T cell responses in the Cloudman M3/DBA/2 model. The CpG-enriched pDNA vaccine induced protection against subsequent challenge with melanoma cells at significantly higher levels than its parental unmodified vector. Preferential induction of an antigen-specific, protective T cell response could be demonstrated by (i) induction of antigen-dependent tumor cell protection, (ii) complete loss of protection by in vivo CD4+/CD8+T cell- but not NK cell-depletion, and (iii) the detection of antigen-specific T cell responses but not of relevant NK cell activity in vitro. These re...Continue Reading

References

Mar 25, 1989·Nucleic Acids Research·G R MacGregor, C T Caskey
Apr 6, 1995·Nature·A M KriegD M Klinman
Feb 1, 1994·European Journal of Immunology·E SchmittE Rüde
Mar 1, 1996·Biological Chemistry Hoppe-Seyler·S PröschD H Krüger
Jan 1, 1997·Annual Review of Immunology·J J DonnellyM A Liu
Nov 5, 1997·Seminars in Immunology·H L Robinson, C A Torres
Mar 24, 1998·Immunology Today·H TigheE Raz
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·A M KriegH L Davis
Feb 15, 2001·Drug Discovery Today·E G. Spack, F L. Sorgi
Jul 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·S BauerG B Lipford
Aug 30, 2001·Proceedings of the National Academy of Sciences of the United States of America·R WangS L Hoffman
Feb 28, 2002·Annual Review of Immunology·Arthur M Krieg
Jul 13, 2002·European Journal of Immunology·Parviz Ahmad-NejadHermann Wagner
Mar 7, 2003·Gene Therapy·H Herweijer, J A Wolff
Jun 5, 2003·International Journal for Parasitology·John DonnellyJeffrey B Ulmer
Jul 2, 2003·Gene Therapy·J A St George
Jul 2, 2003·Nature Medicine·Arthur M Krieg
Sep 17, 2003·Nature Reviews. Immunology·Olivera J Finn

❮ Previous
Next ❯

Citations

Jan 1, 2016·Nucleic Acid Therapeutics·Seyed Moein Moghimi
Aug 4, 2005·The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·A McKechnieO Eremin
Oct 3, 2006·The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·M M AloysiusO Eremin
Mar 11, 2009·Advanced Drug Delivery Reviews·Yogita Krishnamachari, Aliasger K Salem
Mar 4, 2008·Experimental Dermatology·Paul LoriganAxel Hauschild
Nov 17, 2006·The British Journal of Dermatology·M F NaylorR E Nordquist
Apr 23, 2010·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Wolfgang Pfützner
Oct 4, 2005·Neurological Research·Haumith R Khan-FarooqiLinda M Liau
Aug 23, 2006·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·K RassW Tilgen
Jun 15, 2007·International Journal of Cancer. Journal International Du Cancer·Dev KaranDavid M Lubaroff
Jul 20, 2005·Expert Review of Vaccines·Maxim PavlenkoPavel Pisa
Mar 25, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Danson, P Lorigan
Sep 5, 2008·Expert Review of Vaccines·Angela M Bodles-Brakhop, Ruxandra Draghia-Akli
Nov 21, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Marion Jurk, Jörg Vollmer
May 21, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Diane RottembourgMatthias G von Herrath
Sep 3, 2009·Expert Review of Vaccines·Choon-Kit Tang, Geoffrey A Pietersz
Jul 14, 2010·Expert Review of Vaccines·Sheeba Alam, Douglas G McNeel
May 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Barbara G MolenkampTanja D de Gruijl
Dec 20, 2020·Advanced Drug Delivery Reviews·Kyung Soo ParkJames J Moon
Feb 12, 2017·Pharmacology & Therapeutics·Christopher D ZahmDouglas G McNeel
Jun 3, 2021·Pharmaceutics·Saed Abbasi, Satoshi Uchida

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

© 2022 Meta ULC. All rights reserved